CIMG (CIMG) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is CIMG FFO?

FFO (Funds from operations) only applies to REITs.

CIMG Business Description

Address 9 San On Street, Room R2, FTY D, 16th Floor, Kin Ga Industrial Building, Tuen Mun, Hong Kong, HKG
CIMG Inc. is a Hong Kong-based company that operates in the health food and technology sectors. Its operations are organized into segments including Homology of Medicine and Food Series, which produces and distributes health-focused products such as maca peptide coffee, noni, and purified powders; Computing Power Product Series, which involves the sale of technology and computing power equipment; and Maca Product Series. The company's primary revenue driver is the Homology of Medicine and Food Series segment. CIMG serves customers in North America and China, generating revenue through product sales and technology-related contracts. The company has shifted its strategic focus over time, moving from its historical identity as a coffee company toward health products and computing power technology.